Pharmaceuticals

 

Our p2FA technology offers the security of serialisation without the complexity. p2FAs:

• Put product authentication in the hands of the customer, with relying on a change in customer behaviour.

• Eliminate reused package counterfeiting and 'direct-to-customer' sale of fake products. 

• Expand markets by enabling safe online sales.

• Are a package technology that is easily integrated into manufacturing lines.

​

Nucleotrace PITTs may incorporated into the ink of an ADI or, optionally, directly into a pharmaceutical product.

• Increases security, permits rapid forensic analysis of recalled products.

• Allows full lifecycle traceability of all pharmaceutical ingredients over the entire supply chain.

• Supported by FDA and EMA.

​